In 1988, Stillwell et al. reported that 100 patients with CYP (average dose of 4600 cGy)-induced hemorrhagic cystitis developed gross hematuria (78%), irritative voiding symptoms (45%), microhematuria (93%) and bladder cancer (5%) [4]. Here, PPIG is linked to hemorrhagic cystitis.